A simplified and standardized pre- and postoperative treatment technique for Cushing’s syndrome and pheochromocytoma was discussed from experiences on 21 and 18 cases, respectively, treated in our clinic since 1956. Results were summarized as follows: Cushing’s syndrome: A subtotal adrenalectomy with pre- and postoperative irradiation to the hypophysis by a large dosis of telecobalt was effective for the cases with bilateral adrenal hyperplasia. A standard program of postoperative substitution therapy, which was composed of minimized cortisol supplement without ACTH administration, was described. Pheochromocytoma: Three methods presented for blood pressure control after the removal of pheochromocytoma, i.e., noradrenaline drip method, blood overtransfusion method, and the treatment with receptor blocking drugs, were evaluated. Results of the hemodynamic determinations in the pre- and postoperative period were demonstrated. The most reliable management might be obtained from a combined technique with overtransfusion and receptor blockers.

Keywords:
Cushing’s syndrome, Pheochromocytoma
This content is only available via PDF.
© 1971 S. Karger AG, Basel
1971
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.